Mostrar el registro sencillo del ítem

dc.contributor.authorJares, Edgardo J.
dc.contributor.authorCardona, Victoria
dc.contributor.authorGómez, Maximiliano
dc.contributor.authorBernstein, Jonathan A.
dc.contributor.authorRosario Filho, Nelson A.
dc.contributor.authorCherrez-Ojeda, Ivan
dc.contributor.authorEnsina, Luis Felipe
dc.contributor.authorDe Falco, Alicia
dc.contributor.authorDíaz, María C.
dc.contributor.authorChávez Vereau, Pierre A.
dc.contributor.authorRocha Felix, Mara M.
dc.contributor.authorLavrut, Jorge
dc.contributor.authorMoreno Laflor, Oscar I.
dc.contributor.authorLatour Staffeld, Patricia
dc.contributor.authorPiraino, Pedro
dc.contributor.authorAlacaraz Duarte, Perla
dc.contributor.authorIvancevich, Juan C.
dc.contributor.authorDabove, Fabian
dc.contributor.authorGiavina-Bianchi, Pedro
dc.contributor.authorTinoco Moran, Iván O.
dc.contributor.authorNunes Oliviera, Fabiana A.
dc.contributor.authorMonsell, Silvana
dc.contributor.authorSouza, María V.
dc.contributor.authorCepeda, Alfonso M.
dc.contributor.authorSlullitel, Pablo D.
dc.contributor.authorMorfin-Maciel, Blanca M.
dc.date.accessioned2023-09-03T19:01:13Z
dc.date.available2023-09-03T19:01:13Z
dc.date.issued2023-01-23
dc.identifier.citationJares EJ, Cardona V, Gómez RM, Bernstein JA, Rosario Filho NA, Cherrez-Ojeda I, Ensina LF, De Falco A, Díaz MC, Chávez Vereau PA, Rocha Felix MM, Lavrut J, Moreno Laflor OI, Latour Staffeld P, Piraino P, Alacaraz Duarte P, Ivancevich JC, Dabove F, Giavina-Bianchi P, Tinoco Moran IO, Nunes Oliviera FA, Monsell S, Souza MV, Cepeda AM, Slullitel PD, Morfin-Maciel BM. Latin American anaphylaxis registry. World Allergy Organ J. 2023 Feb 5;16(2):100748. doi: 10.1016/j.waojou.2023.100748en_US
dc.identifier.urihttps://repositorio.unphu.edu.do/handle/123456789/5257
dc.description.abstractRecent data about clinical features, triggers and management of anaphylaxis in Latin America is lacking. To provide updated and extended data on anaphylaxis in this region. An online questionnaire was used, with 67 allergy units involved from 12 Latin-American countries and Spain. Among data recorded, demographic information, clinical features, severity, triggering agents, and treatment were received. Eight hundred and seventeen anaphylactic reactions were recorded. No difference in severity, regardless of pre-existing allergy or asthma history was found. Drug induced anaphylaxis (DIA) was most frequent (40.6%), followed by food induced anaphylaxis (FIA) (32.9%) and venom induced anaphylaxis (VIA) (12%). FIA and VIA were more common in children-adolescents. Nonsteroidal anti-inflammatory drugs (NSAIDs) and beta-lactam antibiotics (BLA) were the most frequent drugs involved. Milk (61.1% of FIA) and egg (15.4% of FIA) in children, and shellfish (25.5% of FIA), fresh fruits (14.2% of FIA), and fish (11.3% of FIA) in adults were the most common FIA triggers. Fire ants were the most frequent insect triggers, and they induced more severe reactions than triggers of FIA and DIA (p < 0.0001). Epinephrine was used in 43.8% of anaphylaxis episodes. After Emergency Department treatment, epinephrine was prescribed to 13% of patients. Conclusions: Drugs (NSAIDs and BLA), foods (milk and egg in children and shellfish, fruits and fish in adults) and fire ants were the most common inducers of anaphylaxis. Epinephrine was used in less than half of the episodes emphasizing the urgent need to improve dissemination and implementation of anaphylaxis guidelines.en_US
dc.language.isoenen_US
dc.publisherElsevier Inc. on behalf of World Allergy Organization.en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnafilaxiaen_US
dc.subjectAmérica Latinaen_US
dc.subjectMedicamentosen_US
dc.titleLatin American anaphylaxis registryen_US
dc.typeArticleen_US


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional